SEC Comment Letter 0000000000-24-012342 to BIODESIX INC (BDSX) (CIK 0001439725) (BDSX)

BIODESIX INC (BDSX) (CIK 0001439725)
Date: Nov. 6, 2024 · CIK: 0001439725 · Accession: 0000000000-24-012342

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-282939

Date

November 6, 2024

Author

Division of

Form

UPLOAD

Company

BIODESIX INC (BDSX) (CIK 0001439725)

Letter

Re: Biodesix, Inc. Registration Statement on Form S-3 Filed November 1, 2024 File No. 333-282939 Dear Scott Hutton:

November 6, 2024

Scott Hutton President and Chief Executive Officer Biodesix, Inc. 919 West Dillon Road Louisville, Colorado 80027

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Conlon Danberg at 202-551-4466 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Samir A. Gandhi, Esq.

Show Raw Text

<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
                                                           November 6, 2024

Scott Hutton
President and Chief Executive Officer
Biodesix, Inc.
919 West Dillon Road
Louisville, Colorado 80027

       Re: Biodesix, Inc.
           Registration Statement on Form S-3
           Filed November 1, 2024
           File No. 333-282939
Dear Scott Hutton:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Conlon Danberg at 202-551-4466 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Industrial
Applications and
                                                           Services
cc:   Samir A. Gandhi, Esq.
</TEXT>
</DOCUMENT>

SecProbe.io